Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
ANZ J Surg. 2022 Oct;92(10):2620-2627. doi: 10.1111/ans.17921. Epub 2022 Jul 22.
Pelvic exenteration surgery (PE) offers potentially curative resection for locally advanced malignancy but is associated with significant complexity and morbidity. Specialised teams are recommended to achieve optimal patient outcomes. This study aims to analyse short-term outcomes at a tertiary setting before and after creating a dedicated PE service.
Patients undergoing PE between 2008 and October 2021 at the Royal Adelaide Hospital and St. Andrews Hospital in South Australia were included, with prospective data collection since June 2017. Patients operated on prior and post the creation of the PE service were compared via univariate analyses.
In total, 113 patients were included, with a significant increase in volume of cases post creation of the PE service, (n = 46 pre versus n = 67 post). There were significant differences in the type of neoadjuvant therapy and patient co-morbidity, with more advanced disease stage and a higher likelihood of bone involvement (P < 0.05) in the latter period. An increased proportion of patients had flap reconstruction (40.3 versus 33.9%, P = 0.010) as well as lateral lymph node dissection (13.4 versus 2.2%, P = 0.046). Despite this, peri-operative outcomes such as urosepsis (11.9 versus 28.3%, P = 0.028) and Clavien-Dindo grade of complications grade improved. R0 resections were achieved in 93.9% of curative cases (93.9 versus 84.2%, P = 0.171).
The development of a PE service significantly improved short term patient outcomes, despite the inclusion of patients with more advanced disease and comorbidity.
盆腔廓清术(PE)为局部晚期恶性肿瘤提供了潜在的治愈性切除,但手术具有显著的复杂性和发病率。建议组建专业团队以实现患者的最佳治疗效果。本研究旨在分析在南澳大利亚阿德莱德皇家医院和圣安德鲁斯医院设立专门的盆腔廓清术服务前后的短期治疗结果。
纳入 2008 年至 2021 年 10 月期间在南澳大利亚阿德莱德皇家医院和圣安德鲁斯医院接受盆腔廓清术的患者,自 2017 年 6 月开始进行前瞻性数据收集。通过单变量分析比较创建盆腔廓清术服务前后手术的患者。
共纳入 113 例患者,创建盆腔廓清术服务后手术数量显著增加(n=46 例术前与 n=67 例术后)。在后一时期,新辅助治疗类型和患者合并症存在显著差异,疾病分期更晚,发生骨转移的可能性更高(P<0.05)。更多的患者接受了皮瓣重建(40.3%比 33.9%,P=0.010)和侧方淋巴结清扫术(13.4%比 2.2%,P=0.046)。尽管如此,围手术期结局如尿脓毒症(11.9%比 28.3%,P=0.028)和 Clavien-Dindo 并发症分级均有所改善。在可治愈的病例中,达到了 93.9%的 R0 切除率(93.9%比 84.2%,P=0.171)。
尽管纳入了疾病更晚期和合并症更多的患者,但盆腔廓清术服务的发展显著改善了短期患者结局。